• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向推广传播策略的关键步骤:团队合作最佳实践,用于制作推广材料和监管同仁的合作。

Key Steps Toward a Promotional Communications Strategy: Collaboration Best Practices for Teams Creating Promotional Materials and Regulatory Colleagues.

机构信息

College of Pharmacy, Division of Pharmacy Education and Innovation, The Ohio State University, Columbus, OH, USA.

Bioscience Bridge, LLC, Boise, ID, USA.

出版信息

Ther Innov Regul Sci. 2021 Jul;55(4):696-704. doi: 10.1007/s43441-021-00272-1. Epub 2021 Mar 15.

DOI:10.1007/s43441-021-00272-1
PMID:33723812
Abstract

A promotional communications strategy is considered early in prescription medical product development by commercial disciplines (e.g., commercial/marketing) and informs promotional materials to key stakeholders such as healthcare providers and patients. Health economics and outcomes research (HEOR) is a scientific discipline that is also responsible for the generation of promotional materials to other key stakeholders such as payors. The overarching promotional strategy benefits from consistent partnerships with regulatory affairs colleagues, culminating in cost savings and patient-centric promotional materials. Yet there is a paucity of published content that details effective collaboration between promotional teams and regulatory colleagues prior to medical/legal/regulatory (MLR) review. The following review aims to showcase such organizational innovation from the perspective of teams developing promotional materials (i.e., commercial and HEOR). Behind-the-scenes marketing activities are described in relation to the following key steps that build the strategy's foundation: insight gathering from key stakeholders; sub-strategy development; tactic identification; and promotional message development. Integration of regulatory colleagues with teams developing promotional materials is imperative to accomplish these key steps prior to any MLR review. Finally, four themes in best practices for collaboration with regulatory colleagues are shared from the perspective of commercial disciplines and HEOR, alongside a real-world example for each: (1) Alignment of Strategies; (2) Shared Process & Tools; (3) Creative Problem-Solving; and (4) Culture of Connecting.

摘要

在处方药产品开发过程中,商业部门(例如商业/营销)会考虑制定推广沟通策略,并为关键利益相关者(如医疗保健提供者和患者)提供推广材料。健康经济和结果研究(HEOR)是一门科学学科,也负责为其他关键利益相关者(如支付方)生成推广材料。总体推广策略受益于与监管事务同事的持续合作,最终实现成本节约和以患者为中心的推广材料。然而,很少有发表的内容详细介绍了在医疗/法律/监管(MLR)审查之前,推广团队和监管同事之间的有效合作。以下审查旨在从开发推广材料的团队(即商业和 HEOR)的角度展示这种组织创新。幕后营销活动是根据构建策略基础的以下关键步骤来描述的:从关键利益相关者那里收集见解;制定分战略;确定策略;制定推广信息。在进行任何 MLR 审查之前,将监管同事与开发推广材料的团队整合至关重要。最后,从商业学科和 HEOR 的角度分享了与监管同事合作的最佳实践的四个主题,并提供了每个主题的实际示例:(1)策略一致;(2)共享流程和工具;(3)创造性解决问题;和(4)建立联系的文化。

相似文献

1
Key Steps Toward a Promotional Communications Strategy: Collaboration Best Practices for Teams Creating Promotional Materials and Regulatory Colleagues.迈向推广传播策略的关键步骤:团队合作最佳实践,用于制作推广材料和监管同仁的合作。
Ther Innov Regul Sci. 2021 Jul;55(4):696-704. doi: 10.1007/s43441-021-00272-1. Epub 2021 Mar 15.
2
Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances.临床试验设计与产品推广中的创新:随着监管和技术进步转变患者视角。
Ther Innov Regul Sci. 2019 May 26:2168479019846062. doi: 10.1177/2168479019846062.
3
Social marketing and the creative process: staying true to your social marketing objectives.社会营销与创意过程:坚守你的社会营销目标。
Health Promot Pract. 2011 Sep;12(5):651-3. doi: 10.1177/1524839911421345.
4
Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances.临床试验设计和产品推广的创新:随着监管和技术的进步,从患者的角度不断发展。
Ther Innov Regul Sci. 2020 May;54(3):519-527. doi: 10.1007/s43441-019-00083-5. Epub 2020 Jan 6.
5
Ethical issues in advertising and promotion of medical units.医疗单位广告与推广中的伦理问题。
Rom J Ophthalmol. 2016 Oct-Dec;60(4):216-218.
6
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.医院环境中患者与护士以患者为中心的沟通体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072.
7
Marketing communications in health and medicine: perspectives from Willis-Knighton Health System.健康与医学领域的营销传播:威利斯-克里顿健康系统的观点。
BMC Health Serv Res. 2020 Sep 15;20(Suppl 1):817. doi: 10.1186/s12913-020-05598-4.
8
Evaluation of Promotional Materials To Promote Low-Dose Computed Tomography (LDCT) Screening to High-Risk Consumers and Health Care Providers.评估向高风险消费者和医疗保健提供者推广低剂量计算机断层扫描(LDCT)筛查的宣传材料。
J Cancer Educ. 2018 Oct;33(5):1043-1051. doi: 10.1007/s13187-017-1204-9.
9
Public relations in health and medicine: using publicity and other unpaid promotional methods to engage audiences.卫生与医学中的公共关系:利用宣传和其他非付费的推广手段来吸引受众。
BMC Health Serv Res. 2020 Sep 15;20(Suppl 1):821. doi: 10.1186/s12913-020-05602-x.
10
Foundational elements of communication in health and medicine: avenues for strengthening the marketing communications mix.健康与医学传播的基础要素:加强营销传播组合的途径。
BMC Health Serv Res. 2020 Sep 15;20(Suppl 1):823. doi: 10.1186/s12913-020-05604-9.

本文引用的文献

1
An Evolved Approach to Advisory Boards in Rare Disease Drug Development: 5-Step Model to Finding and Engaging Patient Advisors.罕见病药物研发中咨询委员会的一种改进方法:寻找并吸引患者顾问的五步模型
J Patient Exp. 2020 Dec;7(6):978-981. doi: 10.1177/2374373520948441. Epub 2020 Oct 26.
2
Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances.临床试验设计和产品推广的创新:随着监管和技术的进步,从患者的角度不断发展。
Ther Innov Regul Sci. 2020 May;54(3):519-527. doi: 10.1007/s43441-019-00083-5. Epub 2020 Jan 6.
3
Improving Patient Involvement in Medicines Research and Development:: A Practical Roadmap.
提高患者在药物研发中的参与度:一份实用路线图。
Ther Innov Regul Sci. 2017 Sep;51(5):612-619. doi: 10.1177/2168479017706405. Epub 2017 May 8.
4
Disease Information in Direct-to-Consumer Prescription Drug Print Ads.面向消费者的处方药印刷广告中的疾病信息。
J Health Commun. 2016;21(2):228-39. doi: 10.1080/10810730.2015.1058440. Epub 2015 Dec 30.